Heart drug tested against COVID-19 in High-Risk patients
Disease control
Terminated
This study tested a drug called CardiolRx in 90 hospitalized COVID-19 patients who also had heart disease or risk factors like diabetes, high blood pressure, or obesity. The goal was to see if the drug could lower the chances of death, needing intensive care, or having heart comp…
Phase: PHASE2, PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC